Abvc Biopharma, Inc.
ABVC· Nasdaq
ABVCAbvc Biopharma, Inc.
Who holds Abvc Biopharma, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 374.5K | +96.5% | $591.7K | 0% | Aug 13, 2026 |
| Geode Capital Management, LLC | 228K | +3.1% | $360.4K | 0% | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 97.4K | ±0% | $153.8K | 0% | Aug 13, 2026 |
| State Street Corp | 72.8K | ±0% | $115K | 0% | Sep 22, 2026 |
| Citadel Advisors LLC | 72.1K | New | $113.9K | 0% | Sep 2, 2026 |
| BlackRock, Inc. | 56.4K | ±0% | $89.2K | 0% | Aug 7, 2026 |
| Northern Trust Corp | 48.6K | +51.6% | $76.9K | 0% | Aug 13, 2026 |
| XTX Topco Ltd | 48.3K | New | $76.3K | 0.1% | Aug 14, 2026 |
| Panagora Asset Management Inc | 36.7K | New | $58K | 0.1% | Aug 6, 2026 |
| UBS Group AG | 34.1K | +1,826.8% | $53.9K | 0% | Aug 13, 2026 |
| Jane Street Group, LLC | 20.1K | New | $31.7K | 0% | Aug 14, 2026 |
| Citigroup Inc | 540 | New | $853 | 0% | Aug 3, 2026 |
| LifeSteps Financial, Inc. | 300 | New | $474 | 0.1% | Jul 17, 2026 |
| Caitong International Asset Management Co., Ltd | 6 | New | $9 | 0% | Aug 5, 2026 |
| Royal Bank of Canada | 17 | ±0% | $0 | 0% | Aug 14, 2026 |
